The Sp1 polymorphism in the COLIA1 gene is not associated with BMD or osteoporosis related fractures in the Icelandic population.

被引:0
|
作者
Styrkarsdottir, U [1 ]
Gudjonsdottir, K [1 ]
Johannsdottir, VD [1 ]
Jonasson, K [1 ]
Grant, SFA [1 ]
Thors, H [1 ]
Stefansson, K [1 ]
Gulcher, J [1 ]
Sigurdsson, G [1 ]
机构
[1] Univ Iceland, Univ Hosp, Reykjavik, Iceland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SU133
引用
收藏
页码:S363 / S363
页数:1
相关论文
共 50 条
  • [31] A novel titreplate based assay for the detection of the COLIA1 Sp1 binding site polymorphism associated with increased risk of osteoporotic fracture.
    Scott, CM
    Cribbes, S
    Zajicek, G
    Ralston, S
    Wallace, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S476 - S476
  • [32] COLIA1 Sp1 polymorphism:: towards individualized therapy with injected recombinant hGH in GH-deficient adults?
    Koch, Christian A.
    PHARMACOGENOMICS, 2008, 9 (08) : 987 - 988
  • [33] Linkage disequilibrium between COLIA1 Sp1 and a new 1 bp deletion polymorphism in the upstream regulatory region of the gene in Spanish perimenopausal women.
    Nogues, X
    Garcia-Giralt, N
    Jensen, AB
    Enjuanes, A
    Quintana, S
    Mellibovsky, L
    Puig, J
    Balcells, S
    Grinberg, D
    Díez, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S490 - S490
  • [34] The Sp1 COLIA1 Gene Polymorphism, and Not Vitamin D Receptor or Estrogen Receptor Gene Polymorphisms, Determines Bone Mineral Density in Postmenopausal Greek Women
    Z. Efstathiadou
    V. Kranas
    J. P. A. Ioannidis
    I. Georgiou
    A. Tsatsoulis
    Osteoporosis International, 2001, 12 : 326 - 331
  • [35] The Sp1 COLIA1 gene polymorphism, and not vitamin D receptor or estrogen receptor gene polymorphisms, determines bone mineral density in postmenopausal Greek women
    Efstathiadou, Z
    Kranas, V
    Ioannidis, JPA
    Georgiou, I
    Tsatsoulis, A
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 (04) : 326 - 331
  • [36] Polymorphism analysis in the COLIA1 gene of patients with thalassemia major and intermedia
    Arisal, O
    Deviren, A
    Fenerci, EY
    Hacihanefioglu, S
    Ulutin, T
    Erkmen, S
    Buyru, N
    HAEMATOLOGIA, 2002, 32 (04) : 475 - 482
  • [37] Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes:: The GENOMOS study (vol 3, pg e90, 2006)
    Ralston, Stuart H.
    Uitterlinden, Andre G.
    Brandi, Maria Luisa
    Balcells, Susana
    Langdahl, Bente L.
    Lips, Paul
    Lorenc, Roman
    Obermayer-Pietsch, Barbara
    Scollen, Serena
    Bustamante, Mariona
    Husted, Lise Bjerre
    Carey, Alisoun H.
    Diez-Perez, Adolfo
    Dunning, Alison M.
    Falchetti, Alberto
    Karczmarewicz, Elzbieta
    Kruk, Marcin
    van Leeuwen, Johannes P. T. M.
    van Meurs, Joyce B. J.
    Mangion, Jon
    McGuigan, Fiona E. A.
    Mellibovsky, Leonardo
    del Monte, Francesca
    Pols, Huibert A. P.
    Reeve, Jonathan
    Reid, David M.
    Renner, Wilfried
    Rivadeneira, Fernando
    van Schoor, Natasja M.
    Sherlock, Rachael E.
    Ioannidis, John P. A.
    PLOS MEDICINE, 2006, 3 (05) : 704 - 704
  • [38] The Study of G/T Polymorphism in COLIA1 Gene and Osteoporosis in b-Thalassemia Patients.
    El-Beshlawy, Amal M.
    Hamdy, Mona Mohamed
    Hussein, Ibtesam Ramzy
    Sheba, Bala Fathy
    Gawad, Mona Abdel
    BLOOD, 2009, 114 (22) : 1564 - 1564
  • [39] Promoter and intron 1 polymorphisms of COLIA1 predispose to osteoporosis by regulating transcription and altering binding of Sp1, Nmp4 and osterix
    Jin, H.
    Albagha, O. M. E.
    Van't Hof, R. J.
    Ralston, S. H.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S44 - S45
  • [40] Polymorphisms of the COLIA1 gene predict BMD response to cyclical etidronate therapy.
    Qureshi, AM
    Fogelman, I
    Grant, SFA
    Herd, R
    Blake, G
    Ralston, SH
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S546 - S546